# A Randomized Study Evaluating Steroid Hormone Levels, Safety And Tolerability Of GW870086X In Healthy Volunteers

> **NCT00549497** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 36 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** GW870086X

## Key facts

- **NCT ID:** NCT00549497
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** 2008-01
- **Final completion:** 2008-01
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2017-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00549497

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00549497, "A Randomized Study Evaluating Steroid Hormone Levels, Safety And Tolerability Of GW870086X In Healthy Volunteers". Retrieved via AI Analytics 2026-06-06 from https://api.ai-analytics.org/clinical/NCT00549497. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*